vs
ASSOCIATED BANC-CORP（ASB）与CORCEPT THERAPEUTICS INC（CORT）财务数据对比。点击上方公司名可切换其他公司
ASSOCIATED BANC-CORP的季度营收约是CORCEPT THERAPEUTICS INC的1.9倍（$383.0M vs $202.1M），ASSOCIATED BANC-CORP净利率更高（31.2% vs 12.0%，领先19.2%），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 9.1%）
联合银行集团（Associated Banc-Corp）是美国区域性银行控股公司，总部位于威斯康星州格林贝，深耕美国中西部地区，主营零售银行、商业银行、商业地产贷款、私人银行及特色金融服务，在威斯康星州、伊利诺伊州、明尼苏达州设有220多个营业网点，覆盖100多个社区，还在印第安纳、密歇根等多州设有贷款办事处。
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
ASB vs CORT — 直观对比
营收规模更大
ASB
是对方的1.9倍
$202.1M
净利率更高
ASB
高出19.2%
12.0%
两年增速更快
CORT
近两年复合增速
9.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $383.0M | $202.1M |
| 净利润 | $119.6M | $24.3M |
| 毛利率 | — | 98.7% |
| 营业利润率 | — | 2.2% |
| 净利率 | 31.2% | 12.0% |
| 营收同比 | — | 11.1% |
| 净利润同比 | 566.6% | -21.0% |
| 每股收益（稀释后） | $0.70 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASBCORT
| Q1 26 | $383.0M | — | ||
| Q4 25 | $310.0M | $202.1M | ||
| Q3 25 | $305.2M | $207.6M | ||
| Q2 25 | $300.0M | $194.4M | ||
| Q1 25 | $285.9M | $157.2M | ||
| Q4 24 | $270.3M | $181.9M | ||
| Q3 24 | $329.7M | $182.5M | ||
| Q2 24 | $321.8M | $163.8M |
净利润ASBCORT
| Q1 26 | $119.6M | — | ||
| Q4 25 | $137.1M | $24.3M | ||
| Q3 25 | $124.7M | $19.7M | ||
| Q2 25 | $111.2M | $35.1M | ||
| Q1 25 | $101.7M | $20.5M | ||
| Q4 24 | $-161.6M | $30.7M | ||
| Q3 24 | $88.0M | $47.2M | ||
| Q2 24 | $115.6M | $35.5M |
毛利率ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | — | 98.7% | ||
| Q3 25 | — | 97.8% | ||
| Q2 25 | — | 98.2% | ||
| Q1 25 | — | 98.5% | ||
| Q4 24 | — | 98.4% | ||
| Q3 24 | — | 98.4% | ||
| Q2 24 | — | 98.5% |
营业利润率ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | 52.6% | 2.2% | ||
| Q3 25 | 50.5% | 4.9% | ||
| Q2 25 | 46.5% | 13.7% | ||
| Q1 25 | 42.3% | 2.2% | ||
| Q4 24 | -65.8% | 13.9% | ||
| Q3 24 | 32.8% | 25.5% | ||
| Q2 24 | 32.0% | 21.7% |
净利率ASBCORT
| Q1 26 | 31.2% | — | ||
| Q4 25 | 44.2% | 12.0% | ||
| Q3 25 | 40.9% | 9.5% | ||
| Q2 25 | 37.1% | 18.1% | ||
| Q1 25 | 35.6% | 13.1% | ||
| Q4 24 | -59.8% | 16.9% | ||
| Q3 24 | 26.7% | 25.9% | ||
| Q2 24 | 35.9% | 21.7% |
每股收益（稀释后）ASBCORT
| Q1 26 | $0.70 | — | ||
| Q4 25 | $0.80 | $0.20 | ||
| Q3 25 | $0.73 | $0.16 | ||
| Q2 25 | $0.65 | $0.29 | ||
| Q1 25 | $0.59 | $0.17 | ||
| Q4 24 | $-1.10 | $0.25 | ||
| Q3 24 | $0.56 | $0.41 | ||
| Q2 24 | $0.74 | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $372.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.0B | $647.8M |
| 总资产 | $45.6B | $836.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | — | $372.2M | ||
| Q3 25 | — | $421.7M | ||
| Q2 25 | — | $342.2M | ||
| Q1 25 | — | $322.8M | ||
| Q4 24 | — | $383.3M | ||
| Q3 24 | — | $380.3M | ||
| Q2 24 | — | $473.2M |
总债务ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | — | ||
| Q3 25 | $594.1M | — | ||
| Q2 25 | $593.5M | — | ||
| Q1 25 | $591.4M | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $844.3M | — | ||
| Q2 24 | $536.1M | — |
股东权益ASBCORT
| Q1 26 | $5.0B | — | ||
| Q4 25 | $5.0B | $647.8M | ||
| Q3 25 | $4.9B | $631.9M | ||
| Q2 25 | $4.8B | $635.8M | ||
| Q1 25 | $4.7B | $683.3M | ||
| Q4 24 | $4.6B | $679.6M | ||
| Q3 24 | $4.4B | $638.8M | ||
| Q2 24 | $4.2B | $596.2M |
总资产ASBCORT
| Q1 26 | $45.6B | — | ||
| Q4 25 | $45.2B | $836.7M | ||
| Q3 25 | $44.5B | $823.6M | ||
| Q2 25 | $44.0B | $801.7M | ||
| Q1 25 | $43.3B | $846.5M | ||
| Q4 24 | $43.0B | $840.6M | ||
| Q3 24 | $42.2B | $784.3M | ||
| Q2 24 | $41.6B | $714.6M |
负债/权益比ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | 0.20× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $38.4M |
| 自由现金流经营现金流 - 资本支出 | — | $38.4M |
| 自由现金流率自由现金流/营收 | — | 19.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.58× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | $218.1M | $38.4M | ||
| Q3 25 | $158.0M | $54.5M | ||
| Q2 25 | $141.5M | $43.9M | ||
| Q1 25 | $98.2M | $5.1M | ||
| Q4 24 | $207.1M | $59.3M | ||
| Q3 24 | $105.1M | $73.8M | ||
| Q2 24 | $113.5M | $41.2M |
自由现金流ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | — | $38.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $43.9M | ||
| Q1 25 | — | $5.0M | ||
| Q4 24 | — | $59.2M | ||
| Q3 24 | — | $72.2M | ||
| Q2 24 | — | $40.8M |
自由现金流率ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | — | 19.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 22.6% | ||
| Q1 25 | — | 3.2% | ||
| Q4 24 | — | 32.5% | ||
| Q3 24 | — | 39.5% | ||
| Q2 24 | — | 24.9% |
资本支出强度ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.1% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | — | 0.3% |
现金转化率ASBCORT
| Q1 26 | — | — | ||
| Q4 25 | 1.59× | 1.58× | ||
| Q3 25 | 1.27× | 2.77× | ||
| Q2 25 | 1.27× | 1.25× | ||
| Q1 25 | 0.97× | 0.25× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | 1.19× | 1.56× | ||
| Q2 24 | 0.98× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASB
| Net Interest Income | $307.2M | 80% |
| Noninterest Income | $75.9M | 20% |
CORT
暂无分部数据
